US$ 22.03
oral semaglutide novo nordisk Nordisk's Ozempic® pill, the only FDA-approved peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US Novo Nordisk Wins EU Approval
Description
Recapping the headlines that affected American's health in 2025

It is a once a week injection from Eli Lilly that could treat obesity and Type-2 diabetes

Lost the weight but still look pregnant
Summer bods are the summer fashion

Clinical evidence shows GLP-1 medications can be effective at lower body weight goals when combined with personalized dosing and lifestyle support

Weight loss (WL) is slightly greater in people who experience GI AEs than those who do not
